Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SPARK BIOMEDICAL INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-07-14 to 2026-07-02
Current total value of award: $1149775.19
Description: ARMY PHASE II STTR.